Fermenta Biotec.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE225B01021
  • NSEID:
  • BSEID: 506414
INR
310.35
-17.2 (-5.25%)
BSENSE

Feb 10

BSE+NSE Vol: 1.24 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
137.36
130.22
136.26
139.85
156.47
95.03
78.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
137.36
130.22
136.26
139.85
156.47
95.03
78.13
Raw Material Cost
51.24
32.82
27.52
50.49
25.63
22.61
27.19
Purchase of Finished goods
9.92
16.63
15.62
19.87
21.60
14.00
4.18
(Increase) / Decrease In Stocks
-9.54
-2.89
8.85
-20.24
-1.95
-6.80
-2.18
Employee Cost
20.77
20.14
20.35
16.89
16.98
15.46
15.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.01
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
40.01
36.88
35.69
35.89
40.94
30.97
32.36
Total Expenditure (Excl Depreciation)
112.40
103.58
108.03
102.91
103.20
76.25
77.33
Operating Profit (PBDIT) excl Other Income
24.96
26.64
28.23
36.94
53.27
18.78
0.80
Other Income
3.12
5.43
8.77
3.89
2.23
2.88
2.82
Operating Profit (PBDIT)
28.08
32.07
37.00
40.83
55.50
21.66
3.62
Interest
3.03
2.58
3.11
2.99
4.08
3.69
3.43
Exceptional Items
-2.20
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
22.85
29.49
33.89
37.84
51.42
17.97
0.19
Depreciation
5.37
5.41
5.81
5.86
6.08
6.15
6.12
Profit Before Tax
17.48
24.08
28.09
31.98
45.34
11.82
-5.93
Tax
5.46
6.05
6.49
-1.34
7.45
0.70
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.02
18.03
21.60
33.32
37.89
11.12
-5.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.02
18.03
21.60
33.32
37.89
11.12
-5.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.66
-0.03
-0.23
-1.07
0.98
-0.26
-0.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
12.68
18.06
21.83
34.39
36.91
11.38
-5.82
Equity Capital
14.44
14.55
14.58
14.58
14.58
14.50
14.45
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.39
6.21
7.49
11.79
12.66
3.92
-2.01
Diluted Earnings per share
4.34
6.15
7.47
11.79
12.71
3.94
-2.01
Operating Profit Margin (Excl OI)
18.17%
20.46%
20.72%
26.41%
34.04%
19.76%
1.02%
Gross Profit Margin
16.64%
22.65%
24.87%
27.06%
32.86%
18.91%
0.24%
PAT Margin
8.75%
13.85%
15.85%
23.83%
24.22%
11.7%
-7.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is -12.21% vs 58.10% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -65.65% vs 274.72% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -53.14% vs 112.06% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -25.74% vs -21.39% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Fermenta Biotec. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
137.36
70.34
67.02
95.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
137.36
70.34
67.02
95.28%
Raw Material Cost
51.24
38.54
12.70
32.95%
Purchase of Finished goods
9.92
0.00
9.92
(Increase) / Decrease In Stocks
-9.54
-3.01
-6.53
-216.94%
Employee Cost
20.77
9.89
10.88
110.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
40.01
6.32
33.69
533.07%
Total Expenditure (Excl Depreciation)
112.40
51.75
60.65
117.20%
Operating Profit (PBDIT) excl Other Income
24.96
18.59
6.37
34.27%
Other Income
3.12
0.51
2.61
511.76%
Operating Profit (PBDIT)
28.08
19.10
8.98
47.02%
Interest
3.03
1.78
1.25
70.22%
Exceptional Items
-2.20
0.00
-2.20
Gross Profit (PBDT)
22.85
17.32
5.53
31.93%
Depreciation
5.37
6.37
-1.00
-15.70%
Profit Before Tax
17.48
10.95
6.53
59.63%
Tax
5.46
0.70
4.76
680.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.02
10.25
1.77
17.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.02
10.25
1.77
17.27%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.66
0.00
-0.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.68
10.25
2.43
23.71%
Equity Capital
14.44
22.25
-7.81
-35.10%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.39
4.61
-0.22
-4.77%
Diluted Earnings per share
4.34
4.59
-0.25
-5.45%
Operating Profit Margin (Excl OI)
18.17%
26.43%
0.00
-8.26%
Gross Profit Margin
16.64%
24.62%
0.00
-7.98%
PAT Margin
8.75%
14.57%
0.00
-5.82%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 137.36 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 5.48% vs -4.43% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -12.21% vs 58.10% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.68 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -29.79% vs -17.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -65.65% vs 274.72% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.96 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -6.31% vs -5.63% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -53.14% vs 112.06% in Dec 2024

Quarterly - Interest
Interest 3.03 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 17.44% vs -17.04% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -25.74% vs -21.39% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.17%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024